Τόμος 11 (1997) – Τεύχος 2 & 3 – Άρθρο 13 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 11 (1997) – Issue 2 & 3 – Article 13 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. Department of Obstetrics and Gynecology, Medical School, University of Patras, 265 10 Patra, Greece

2. Department of Chemistry, University of Patras, 265 00 Patra, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.  Hopkinson C.R.N,, Pant H., Fitzpatrick R.J.: Release of LH and FSH in the normal and intact ram by synthetic LH-RF and the effect of pretreatment with testosterone propionate. J. Reprod. Fertil. 39: 135-139 (1974)

3.  Kanchev L.N., Dobson M., Stankov B.M.: Early pituitary response to injections of GnRH in ewes. Theriogenoiogy 21: 407-417 (1984)

4.  Bremner W.J,, Paulsen C.A.: Two pools of luteinizing hormone in the human pituitary: evidence from constant administration of luteinizing hormone releasing hormone. J. Clin. Endocrinol Metab. 39: 811-815 (1974)

5.  Savoy Moor R.T., Schwartz N.B., Duncan J.A., Mashall J.C.: Pituitary gonadotropin-releasing hormone receptors during the rat estrous cycle. Science 109: 942-944 (1980)

6.  Adams T.E., Spies T.G.: Binding characteristics of gonadotropin-releasing hormone receptors through estrous cycles of the hamster. Endocrinology 108: 2245-2253 (1981)

7.   Schoenemann H.M, Brown J.A., Reeves J.J.: Pituitary LHRH receptors in noncycling, cycling and pregnant beef hefers. J. Anim. Sci. 60: 532-536 (1985)

8.  Brooks I., Taylor P.L., Saunders P.T.K., Eidne K.A., Struthes W.J., McNeilly A.S.: Cloning and sequencing of the sheep pituitary-gonadotropin releasing hormone receptor and changes in expression of its mRNA during the estrous cycle. Mot. Cell Endocrinol. 94: 1223-1227 (1993)

9.  Eidne K.A., Sellar R.E., Camper G., Anderson L., Taylor L.P.: Molecular cloning and characterization of the rat pituitary gonadotropin-releasing hormone (GnRH) receptor. Mol. Cell Endocrinol. 90: 125-129 (1992)

10.            Bauer-Dantoin A.C., Hollentzerg A.N., Jameson J.L.: Dynamic regulation of gonadotropin-releasing hormone receptor mRNA levels in the anterior pituitary gland during the rat estrous cycle. Endocrinology 133: 1911-1914 (1993)

11. Turillo A.M., Campion C.E., Clan C.M., Nett R.M.: Regulation of gonadotropin-releasing hormone (GnRH) receptor messenger ribonucleic acid and GnRH receptors during the early prbovulatory period in the ewe. Endocrinology 135: 1335-1358 (1993)

12.            Stojikovic S.S., Reinhart J., Catt K.T.: Gonadotropin-re- leasing hormone receptors: Structure and signal transduction pathway. Endocr. Rev. 75: 462-499 (1994)

13.            Padmanabhan V., Palkin A., Yasin M., Haisenleder D.J., Marshall J.C., Landefeld T.D.: Are immediate early genes involved in gonadotropin-releasing hormone receptor gene regulation? Characterization of changes in GnRH receptor (GnRH-A), c-fos and c-jun messenger ribonucleic acids during the ovine estrous cycle. Biol. Reprod. 53: 263-269 (1995)

14.            Sheng M., McFadden G., Greenberg M.E.: Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor. CREB Neuron. 4: 571-582 (1990)

15.            Casini A., Galli G., Salzano R., Geni F., Franceschetti F., Rotella C.M., Surrenti C.: Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation Alcohol Alcohol. 29: 303-314 (1994)

16.            Schally A.V., Kastin A.J., Coy D.H.: LH-releasing hormone and its analogues: Recent basic and clinical investigations. Int. J. Fértil. 20: 1 (1987)

17.             IVF-ET in United States. 1990 results from IVF-ET Registry. Fertil. Steril. 57: 15-24 (1992)

18.            Pavlou J.N.: The mechanism of action of GnRH agonists. In: (Polal M.L., Henzl M.R., eds) Infertility and reproductive medicine. Clinics of North America Philadelphia: WB Saunders, pp. 9-19,1993

19.            Loumaye E., Vankrieken I., Depreester S., Psalti I., De Cooman S., Thomas K.: Hormonal changes induced by short term administration of a GnRH agonist during ovarian, hyperstimulation for IVF and their consequences for embryon development. Fértil. Steril. 57: 105-111 (1989)

20.            Schally A.V.C., Srkalovic G., Szende B., et al.: New antagonistic analogues of LHRH experimental oncological and clinical studies. In: (Lunenfeld B., ed.) Advances in the study of GnRH analogues. Volume 2, pp. 25-35, The basic science of GnRH analogues. Lancaster, England, Parthenon, 1992

21.            Pavlou S.N.. GnRH antagonists in men In: (Crowley WF, Conn PM, eds) Modes of action of GnRH and GnRH analogs. Pp. 298-309, Springer Verl, New York, 1991

22.            Mortola J.F. Sathanandom M., Pavlou S.N., et al.: Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent go- nadotropin-releasing hormone antagonist: pharmacodynamic studies. Fertit. Steril. 91: 957-963 (1989)

23.            Kolp L.A., Pavlou S.N., Urban R.J., Rivier J.C., Vale W.W., Veldhuis J.D.: Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone- stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women. J. Clin. Endocrinol. Metab. 75: 993-997 (1992)

24.            Minaretzis D., Jakubowski M., Mortola J.F., Pavlou S.N.: Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosalutein cells [Abstract 076]. In: Proceedings of the forty-first Annual Meeting of the Society for Gynecologic Investigation, Chicago, Illinois, March 22-26; 1994. Chicago Society for Gynecologic Investigation: 124 (1994)

25.            Minaretzis D., Alper M.M., Oskowitz S.P., Lober S.M., Mortola J.F., Pavlou S.N.: Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: Cycle performance and in vitro steroidogenesis of granulosa-lutein cells. Am. J. Obstet. Gynecol. 172: 1518-1525 (1995)

26.            Gallagher C.J., Oliver R.T.D., Oram D.H., et al.: A new treatment for endometrial cancer with gonadotropin releasing-hormone analogue. Br. J. Obstet. Gynecol. 98: 1037-1041 (1991)

27.            Tolis G., Ackman D., Stellos A., et al.: Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. Proc. Natl. Acad. Sci. USA 79: 1658-1662 (1982)

28.            Segal-Abramson R., Kitroser H., Levy J., Schally A.V., Sheroni Y.: Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF 7 mammary cancer cells. Proc. Natl. Acad. Sci. USA 89: 2336-2339 (1992)

29.            Emons G., Becker M., Ortmann O., Laun R., Schulz K.- D., Schally A.V.: Direct antiproliferative effects of LH-RH analogues in cell lines of human epithelial ovarian cancer [Abstract], In: Proceedings of the twenty-fourth Annual Meeting of the American Endocrine Society 1992. Am. Endocr. Soc.: 314 (1992)

30.            Miller W.R., Scott W.M., Murri S.R., Fraser H.M., Sharpe R.M.: Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313: 231-233 (1985)

31.            Fekete M., Redding T.W., Comara-Schally A.M., et al.: Receptor for luteinizing hormone-releasing hormones, somatostatin, prolactin and epidermal growth factor in rat and human prostate cancer and in benign prostate hyperplasia. Prostate 14: 191-208 (1989)

32.            Fekete M., Zalatnai A., Comaru-Schally A.M., Schally A.V.: Membrane receptors for peptides in experimental and human pancreatic cancer. Pancreas 4: 521-528 (1989)

33.            Pahwa G.S., Kullander S., Vollnor G., Oberhenser F., Knuppen R., Emons C.: Specific low affinity binding sites for gonadotropin-releasing hormone in human endometrial carcinoma. Eur. J. Obstet. Gynecol. Reprod. Biol. 41: 135-142 (1991)

34.            Srkalovic G., Wittlibf J.L., Schally A.V.: Detection and partial characteriration of receptors for [D-Trp⁶]luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res. 50: 1841-1846 (1990)

35.            Kleinman D., Douvdevani A., Schally A.V., Levy J., Sharoni Y.: Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis. Am. J. Obstet. Gynecol. 170: 96-102 (1994)

36.            Inslero V., Lunenfeld B.: Application of GnRH analogues In the treatment of female infertility. In: GnRH Analogues. The Stale of the Art (B. Lunefeld, V. Inslero, eds). P. 37, The Parthenon Publishing Group, Casterton Hall, Carnfort U.K., 1993

37.            Filicori M., Flamigni G., Cognigni G., Delloni P., Amove R., Falho A., Capelli M.: Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women. J. Clin. Endocrinol. Metab. 77: 130-133 (1993)

38.            Sauten R.J., Manni A., Harvey H., Redmont C.: Endocrine treatment of breast cancer in women. Endocrine Rev. 11: 221-265 (1990)

39.            Proceedings of the Second International EORTC Symposium on Hormonal Manipulation of Cancer. Peptides, growth factors and new (anti) steroidal agents. J. Steroid. Biochem. Moi. Biol. 27: 747-1120 (1990)

40.            Hirayama T., Wynder E.L.: Study of epidemiology of cancer of the breast influence of hysterectomy. Cancer 15: 28-38 (1962)

41.            Henderson B.E., Ross R.K., Pike M.C.: Hormonal chemoprevention of cancer in women. Science 259: 633-638 (1993)

42 Jones A.L., Powles R.J.: Chemoprevention of breast cancer. Reviews on endocrine-related. Cancer 43: 33-42 (1993)

43. Tzingounis V.A., Cardamakis E.: Danazol versus triptorelin for the management of infertility due to atypical endometriosis. GORM 1995 (In press)

44. Neneu S., Hedon B., Bringer J, et al.: Ovarian stimulation by a combination of gonadotropin releasing hormone agonist and gonadotrophins for in vitro fertilization. Fertil. Steril. 41: 639-642 (1981)

45.            Mac Lachlan V., Besanko M., O’Shea F., et al.: A controlled trial of luteinizing hormone-releasing hormone agonist (Buserelin) for the induction of folliculogenesis before in vitro fertilization. N. Engl. J. Med. 320: 1233-1237 (1989)

46.            Pellicer A., Simon C., Miro F., et al.: Ovarian response and outcome of in vitro fertilization in patients treated with gonadotrophin releasing hormone analogues in different phases of the menstrual cycle. Hum. Reprod. 4: 285-289 (1989)

47.            Loutradis D., Kallianidis P., Drakakis R., Bletsa N., Eleftheriou N.t Milingos S., Creatsas G., Michalas S., Aravantinos D.: Comparison between intranasal and intramuscular administration of gonadotropin-releasing hormone analogues for in vitro fertilization. It. J. Gynaecol Obstet 2: 32- 36 (1992)

48.            Martin M.C., Givers C.R. Schriok E.D., Glass R.H., Dandekar P.V.: The choice of a gonadotropin-releasing hormone analog influences outcome of in vitro fertilisation treatment Am. J. Obstet. Gynecol. 170: 1629-1634 (1994)

49.            Marcus S.F., Edwards R.G.: High rates of pregnancy after long-term down-regulation of women with severe endometriosis. Am. J. Obstet. Gynecol. 171: 812-817 (1994

50.            Tan S.L., Maconochie N., Doyle P., Campbell S., Balen A., Bekir J., Brinsden P., Edwards R.G., Jacobs H.S.: Cumulative conception and live-birth rates after in vitro fertilization with and without use of long, short and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am. J. Obstet. Gynecol. 171: 513-520 (1994)

51.            Dmitry E.S., Bates J.A., Oskarsson R., Margara R.N., Winston R.M.L.: Programming in vitro fertilization for a 5- or 3-day week. Fertil. Steril. 55: 934-938 (1991)

52.            Fiorini F., Migliorati E., Tedeschi L., Angelini R., Lauro V.: GnRH analogues in uterine fibromyoma treatment. Gynec. Endocrin. FC. 177 (1995)

53.            Audebert A.J.M., Mandella P., Quereen D., Pontonnier R.. Racinet C.( Renaud R., Gillet J.-Y., Randrant D.L., Lansa J., Brettes J.-P.: Differed versus immediate surgery for uterine fibroids clinical trial results. Br. J. Obst. Gynaecol. 101 (Suppl 10): 29-32 (1994)

54.            Tzingounis V.A., Cardamakis E., Pappas A., Coutras J.: Treatment of benign breast disease with triptorelin. P. 219, 8th International Congress on Senology, Rio de Janeiro (Brasil), 8-12 May 1994

55.            Creatsas G., Hassan E., Deligeoroglou E., Tolis G., Aravantinos D.: Treatment of polycystic ovarian disease during adolescence with ethinylestradiol/cyproterone acetate versus a D-Tr-6-LHRH analog. Int. J. Gynecol. Obstet. 42: 147-153 (1993)

56.            Root A.W.: Will GnRH analogues increase adult height in girls with precocious puberty. Contemporary Ob/Gy: 51-60 (1995)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr